EZH2 and melanoma: Ageing in fibroblasts induced Enhancer of zeste homolog 2 (EZH2) decline and increased Bone Morphogenetic Protein 2 (BMP2) secretion, these mechanisms induce slower-cycling, highly invasive and therapy-resistant melanomas.